P53 deficiency affects cholesterol esterification to exacerbate hepatocarcinogenesis
Article 2022 en
Authors
YZ
Yahui Zhu
LG
Li Gu
XL
Xi Lin
Abstract
1 min read
Collectively, our findings demonstrate that SOAT1 participates in HCG by increasing cholesterol esterification, thus indicating that SOAT1 is a potential biomarker and therapeutic target in P53-deficient HCC.
Helin Vakifahmetoglu-Norberg, Minsu Kim, Hongguang Xia, Marcin Iwanicki, Dimitry Ofengeim, Jonathan L. Coloff, Lifeng Pan, Tan A. Ince, Guido Guido Kroemer, Joan S. Brugge, Junying Yuan
Sean P. Cregan, Andre Fortin, Jason G. MacLaurin, Steven M. Callaghan, Francesco Cecconi, Seong-Woon Yu, Ted M. Dawson, Valina L. Dawson, David S. Park, Guido Guido Kroemer, Ruth S. Slack
Discussion(0)
No comments yet. Be the first to comment.